In this article, Todd Petersen, CEO of VitalSkin Dermatology, discusses how to protect your practice from financial impropriety in its various forms.
Todd Petersen, CEO of VitalSkin Dermatology, offers more insight into the legal and financial implications of selling your dermatology practice. In this article, he explains various types of sales structures and highlights tax considerations to keep in mind.
Stem cell factor, a growth factor critical for melanocyte survival, may play an important role in the development of benign and malignant skin hyperpigmentation disorders.
Oral tranexamic acid combined with low fluence 1064 nm Q-switched Nd: YAG laser is an effective and safe melasma treatment, with outcomes that are better than oral tranexamic acid alone, according to a recent study.
Soliton has received 510(k) clearance from the U.S. FDA for its Generation II Rapid Acoustic Pulse (RAP) device for tattoo removal.
Switching patients with moderate-to-severe plaque psoriasis from one biologic to another is a multifactorial decision and may depend on safety, efficacy or dosing intervals. Ron Vender, M.D., offers insight into how to switch appropriately.
Topical ivermectin cream, 1% (Soolantra, Galderma) represents an advance in treatment for rosacea, offering superior efficacy and tolerability compared with previously available therapies, says Jeffrey S. Fromowitz, M.D., who spoke at the Orlando Dermatology Aesthetic & Clinical Conference.
In this Legal Eagle article, David J. Goldberg, M.D., J.D., discusses whether or not you can pay a patient to leave your practice.
Introducing The Mainstream Patient, a weekly glimpse into what your patients may be reading in the media about skin health.